Molbio Diagnostics Share Price
09 Nov, 2026 3:54 PM (IST)
Molbio Diagnostics Performance
- Today's Low
- ₹1,322
- Today's High
- ₹1,371
- 52 Week Low
- ₹926
- 52 Week High
- ₹1,687
- Open Price₹1,357
- Previous Close₹1,360
- Volume178,810
- 50 DMA₹1,299.10
- 100 DMA-
- 200 DMA-
Molbio Diagnostics Chart
Investment Returns
- Over 1 Month -7.13%
- Over 3 Month + 65.55%
- Over 6 Month + 65.55%
- Over 1 Year + 65.55%
Smart Investing Starts Here Start SIP with Molbio Diagnostics for Steady Growth!
Molbio Diagnostics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 99.7
- PEG Ratio
- -
- Market Cap Cr
- 15,396
- P/B Ratio
- 13.2
- Average True Range
- 86.4
- EPS
- 13.4
- Dividend Yield
- 0
- MACD Signal
- 4.1
- RSI
- 49.57
- MFI
- 48.06
Latest Stock News Updates
Submission of Newspaper Adverstisement of Un-audited Financial Results (Standalone & Consolidated) for the quarter and half year ended September 30, 2026
- BSE India
- 1 day 9 hours ago
Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company
- BSE India
- 4 days 4 hours ago
<h3><span style="font-size:16px;"><strong>Healthcare Services company Molbio Diagnostics announced Q2FY27 results</strong></span></h3> <p><strong>Standalone Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIDBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="VJYMYb_2p"> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Revenue from Operations:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone revenue from operations stood at Rs 2,488.79 million<!--TgQPHd|||[]-->, representing a sequential decrease of 37.68% QoQ from Rs 3,993.78 million in Q1FY27 and a YoY drop of 57.04% compared to Rs 5,793.11 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, standalone revenue from operations reached Rs 6,482.57 million<!--TgQPHd|||[]-->, up 3.90% YoY against Rs 6,746.31 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Total Income:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone total income recorded Rs 2,528.50 million<!--TgQPHd|||[]-->, demonstrating a decline of 36.90% QoQ from Rs 4,007.46 million in Q1FY27 and down 56.47% YoY from Rs 5,809.01 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, standalone total income reached Rs 6,535.96 million<!--TgQPHd|||[]-->, showing a YoY decline of 3.56% against Rs 6,777.03 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Profit Before Tax (PBT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone PBT came in at Rs 423.53 million<!--TgQPHd|||[]-->, showcasing a drop of 44.22% QoQ from Rs 759.24 million in Q1FY27 and a decline of 65.61% YoY compared to Rs 1,231.67 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, standalone PBT touched Rs 1,182.77 million<!--TgQPHd|||[]-->, representing a growth of 11.89% YoY from Rs 1,057.06 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Profit After Tax (PAT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone PAT stood at Rs 313.78 million<!--TgQPHd|||[]-->, indicating a drop of 44.59% QoQ from Rs 566.27 million in Q1FY27 and down 65.88% YoY against Rs 919.60 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, standalone PAT reached Rs 880.05 million<!--TgQPHd|||[]-->, which is a YoY expansion of 12.03% compared to Rs 785.55 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Earnings Per Equity Share (EPS):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, standalone basic and diluted EPS came in at Rs 2.75<!--TgQPHd|||[]--> (dropping 45.22% QoQ from Rs 5.02 in Q1FY27 and down 66.30% YoY from Rs 8.16 in Q2FY26). For H1FY27<!--TgQPHd|||[]-->, standalone basic and diluted EPS registered at Rs 7.76<!--TgQPHd|||[]-->, growing 11.33% YoY against Rs 6.97 in H1FY26.<!--TgQPHd|||[]--></li> </ul> <p><!--TgQPHd|||[]--></p> <p><strong>Consolidated Financial Highlights:</strong><!--TgQPHd|||[[2,[null,null,1,null,null,null,null,null,null,null,null,null,[351768,null,0]],[],null,1]]--></p> <ul data-complete="true" data-hveid="CAAIDBAA" data-processed="true" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="wiLEJc#NS0kde" jsuid="VJYMYb_2p"> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Revenue from Operations:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated revenue from operations stood at Rs 2,590.20 million<!--TgQPHd|||[]-->, sequential decrease of 36.57% QoQ compared to Rs 4,083.76 million in Q1FY27 and a drop of 55.36% YoY from Rs 5,802.67 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, consolidated revenue from operations marked Rs 6,673.96 million<!--TgQPHd|||[]-->, a lower turn of 1.85% YoY from Rs 6,799.75 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Total Income:<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated total income logged Rs 2,647.94 million<!--TgQPHd|||[]-->, shedding 35.65% QoQ from Rs 4,114.76 million in Q1FY27 and sliding 54.45% YoY from Rs 5,813.59 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, consolidated total income came to Rs 6,762.70 million<!--TgQPHd|||[]-->, soft by 0.81% YoY compared to Rs 6,818.27 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Profit Before Tax (PBT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated PBT reached Rs 175.05 million<!--TgQPHd|||[]-->, which is 76.94% QoQ lower than Rs 759.09 million in Q1FY27 and down 88.15% YoY against Rs 1,477.40 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, consolidated PBT touched Rs 934.14 million<!--TgQPHd|||[]-->, illustrating a decrease of 19.79% YoY over Rs 1,164.62 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Profit After Tax (PAT):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated PAT registered at Rs 77.01 million<!--TgQPHd|||[]-->, translating to an 85.40% QoQ reduction over Rs 527.44 million in Q1FY27 and falling 92.79% YoY over Rs 1,068.43 million in Q2FY26. For H1FY27<!--TgQPHd|||[]-->, consolidated PAT finished at Rs 604.45 million<!--TgQPHd|||[]-->, down 27.09% YoY from Rs 828.99 million in H1FY26.<!--TgQPHd|||[]--><!--TgQPHd|||[]--></li> <li data-complete="true" data-hveid="CAAIDBAB" data-sae="" data-sfc-cp="" data-sfc-root="c" jsaction="" jscontroller="oSLmPe#HokZ0d" jsuid="VJYMYb_2q">Earnings Per Equity Share (EPS):<!--TgQPHd|||[]--> For Q2FY27<!--TgQPHd|||[]-->, consolidated basic and diluted EPS stood at Rs 1.33<!--TgQPHd|||[]--> (down 74.47% QoQ from Rs 5.21 in Q1FY27 and down 86.34% YoY from Rs 9.74 in Q2FY26). For H1FY27<!--TgQPHd|||[]-->, consolidated basic EPS was Rs 6.52<!--TgQPHd|||[]--> (down 14.55% YoY from Rs 7.63 in H1FY26) and consolidated diluted EPS was Rs 6.51<!--TgQPHd|||[]--> (down 14.68% YoY from Rs 7.63 in H1FY26).</li> </ul> <p><a class="lb" href="/get-document/post/pdf/5935044/" target="_blank">Result PDF</a></p>
- Trendlyne
- 4 days 12 hours ago
Molbio Diagnostics Financials
Molbio Diagnostics Technicals
EMA & SMA
- Bearish Moving Average 9
- Bullish Moving Average 2
- 20 Day
- ₹1,346.70
- 50 Day
- ₹1,299.10
- 100 Day
- -
- 200 Day
- -
Resistance and Support
- R3 1,412.10
- R2 1,391.30
- R1 1,363.70
- S1 1,315.30
- S2 1,294.50
- S3 1,266.90
Molbio Diagnostics Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-11-05 | Quarterly Results | |
| 2026-09-05 | Quarterly Results |
About Molbio Diagnostics
Molbio Diagnostics are an innovative point-of-care (“POC”) diagnostics company focused on expanding access to accurate, rapid and cost-effective healthcare technologies to diagnose infectious and non-communicable diseases. View More- NSE Symbol
- MOLBIO
- BSE Symbol
- 544866
- ISIN
- INE869T01028
Similar Stocks to Molbio Diagnostics
Popular Stocks
Molbio Diagnostics FAQs
Molbio Diagnostics share price is ₹1,336 As on 11 November, 2026 | 00:27
The Market Cap of Molbio Diagnostics is ₹15396.1 Cr As on 11 November, 2026 | 00:27
The P/E ratio of Molbio Diagnostics is 99.7 As on 11 November, 2026 | 00:27
The PB ratio of Molbio Diagnostics is 13.2 As on 11 November, 2026 | 00:27
The 52 week High & Low of Molbio Diagnostics is ₹1686.8/₹926.4 respectively As on 11 November, 2026 | 00:27
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.